Evidence map›Paper›PMID 35805133›Full record

ArticleCells2022

Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations.

Cristina Pardo-Camacho, John-Peter Ganda Mall, Cristina Martínez, Marc Pigrau, Elba Expósito, Mercé Albert-Bayo, Elisa Melón-Ardanaz, Adoración Nieto, Bruno Rodiño-Janeiro, Marina Fortea and 10 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 3 countries.

Cristina Pardo-CamachoLaboratory of Translational Mucosal Immunology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
John-Peter Ganda MallLaboratory of Translational Mucosal Immunology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Cristina MartínezVascular and Renal Translational Research Group, Lleida Institute for Biomedical Research Dr. Pifarré. Foundation (IRBLleida), Av. Alcalde Rovira Roure 80, 25198 Lleida, Spain.
Marc PigrauLaboratory of Neuro-Immuno-Gastroenterology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Elba ExpósitoLaboratory of Translational Mucosal Immunology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Mercé Albert-BayoLaboratory of Translational Mucosal Immunology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.ORCID 0000-0002-9726-8083
Elisa Melón-ArdanazLaboratory of Translational Mucosal Immunology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Adoración NietoLaboratory of Neuro-Immuno-Gastroenterology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Bruno Rodiño-JaneiroLaboratory of Neuro-Immuno-Gastroenterology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Marina ForteaLaboratory of Translational Mucosal Immunology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.ORCID 0000-0001-8885-7495
Danila GuagnozziLaboratory of Translational Mucosal Immunology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Amanda Rodriguez-UrrutiaFacultat de Medicina, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
Inés de TorresFacultat de Medicina, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.ORCID 0000-0002-5495-9140
Ignacio Santos-BrionesFacultat Ciències de la Salut, Universitat Ramon LLull-Blanquerna, C/Padilla 326, 08025 Barcelona, Spain.
Fernando AzpirozDepartment of Gastroenterology, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.ORCID 0000-0002-7327-960X
Beatriz LoboLaboratory of Neuro-Immuno-Gastroenterology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Carmen Alonso-CotonerLaboratory of Neuro-Immuno-Gastroenterology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.ORCID 0000-0002-3483-2919
Javier SantosLaboratory of Neuro-Immuno-Gastroenterology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Ana M González-CastroLaboratory of Translational Mucosal Immunology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.ORCID 0000-0003-3955-3318
Maria VicarioLaboratory of Translational Mucosal Immunology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Vall d'Hebron Institut de Recerca · ESUniversitat Autònoma de Barcelona · ESInstituto de Investigación Biomédica de Lleida · ESInstituto de Salud Carlos III · ESLinköping University · SEUniversitat Ramon Llull · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Irritable bowel syndrome (IBS) is a disorder of brain-gut interaction characterised by abdominal pain and changes in bowel habits. In the diarrhoea subtype (IBS-D), altered epithelial barrier and mucosal immune activation are associated with clinical manifestations. We aimed to further evaluate plasma cells and epithelial integrity to gain understanding of IBS-D pathophysiology. One mucosal jejunal biopsy and one stool sample were obtained from healthy controls and IBS-D patients. Gastrointestinal symptoms, stress, and depression scores were recorded. In the jejunal mucosa, RNAseq and gene set enrichment analyses were performed. A morphometric analysis by electron microscopy quantified plasma cell activation and proximity to enteric nerves and glycocalyx thickness. Immunoglobulins concentration was assessed in the stool. IBS-D patients showed differential expression of humoral pathways compared to controls. Activation and proximity of plasma cells to nerves and IgG concentration were also higher in IBS-D. Glycocalyx thickness was lower in IBS-D compared to controls, and this reduction correlated with plasma cell activation, proximity to nerves, and clinical symptoms. These results support humoral activity and loss of epithelial integrity as important contributors to gut dysfunction and clinical manifestations in IBS-D. Additional studies are needed to identify the triggers of these alterations to better define IBS-D pathophysiology.

Indexed as

Irritable Bowel SyndromeDiarrheaGlycocalyxHumansIntestinal MucosaNerve FibersPlasma CellsIBS-Dintestinal barrier dysfunctionintestinal glycocalyxintestinal plasma cellsmucosal nerve fibresmucosal ultrastructure

Identifiers

PMID35805133
PMCPMC9265332
OpenAlexW4283704823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.